Intern Spotlight: Huibert-Jan Joosse

Intern Spotlight: Gaby Ooms

Intern Spotlight: Linnea Celik

Intern Spotlight: Brian Tielrooij

Intern Spotlight: Anneke Johnson

November is ‘Intern Spotlight Month’ at Health Action International

Conference on Clinical Drug Trials is Coming Up—and You’re Invited

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69

Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event

ACCISS Infographics

Farewell to Access to Medicines Pioneer, Andrew Herxheimer

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E


HAI/WHO Pharmaceutical Promotion Manual Still Key to Combating Promotion around the World

Three Keys to Curbing Antibiotic Resistance

It’s Time Everyone Knows about Price Inequities in Insulin

HSA4A Signs Partnership Agreement to Address Sexual and Reproductive Health and Rights in East Africa

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

Can the WHO Set the Right Course for Antibiotics?

HAI urges MEPs to support key amendments to TTIP resolution

Successful week of advocacy for HAI delegation at 68th World Health Assembly

The EU-US Trade Deal Could Leave Europeans Sick

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases

HAI Launches Innovative Global Study to Improve Access to Insulin

In memory of our Foundation Board Chair, Atze Sybrandy


More work needed on new EMA conflicts of interest policy

Student Stop AIDS National Gathering an inspiring start to Access to Medicines Week

EMA policy on clinical data publication a step ahead, but falls short of true potential

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry